Literature DB >> 15731257

Functional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus production.

Paolo Abada1, Beth Noble, Paula M Cannon.   

Abstract

Primate lentiviruses code for a protein that stimulates virus production. In human immunodeficiency virus type 1 (HIV-1), the activity is provided by the accessory protein, Vpu, while in HIV-2 and simian immunodeficiency virus it is a property of the envelope (Env) glycoprotein. Using a group of diverse retroviruses and cell types, we have confirmed the functional equivalence of the two proteins. However, despite these similarities, the two proteins have markedly different functional domains. While the Vpu activity is associated primarily with its membrane-spanning region, we have determined that the HIV-2 Env activity requires both the cytoplasmic tail and ectodomain of the protein, with the membrane-spanning domain being less important. Within the Env cytoplasmic tail, we further defined the necessary sequence as a membrane-proximal tyrosine-based motif. Providing the two Env regions separately as distinct CD8 chimeric proteins did not increase virus release. This suggests that the two domains must be either contained within a single protein or closely associated within a multiprotein oligomer, such as the Env trimer, in order to function. Finally, we observed that wild-type levels of incorporation of the HIV-2 Env into budding viruses were not required for this activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15731257      PMCID: PMC1075700          DOI: 10.1128/JVI.79.6.3627-3638.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  74 in total

1.  Naturally occurring amino acid substitutions in the HIV-2 ROD envelope glycoprotein regulate its ability to augment viral particle release.

Authors:  Stephan Bour; Hirofumi Akari; Eri Miyagi; Klaus Strebel
Journal:  Virology       Date:  2003-04-25       Impact factor: 3.616

2.  AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding.

Authors:  Bettina Strack; Arianna Calistri; Stewart Craig; Elena Popova; Heinrich G Göttlinger
Journal:  Cell       Date:  2003-09-19       Impact factor: 41.582

3.  HIV-1 egress is gated through late endosomal membranes.

Authors:  Sascha Nydegger; Michelangelo Foti; Aaron Derdowski; Paul Spearman; Markus Thali
Journal:  Traffic       Date:  2003-12       Impact factor: 6.215

Review 4.  Viroporins.

Authors:  Maria Eugenia Gonzalez; Luis Carrasco
Journal:  FEBS Lett       Date:  2003-09-18       Impact factor: 4.124

Review 5.  The HIV-1 Vpu protein: a multifunctional enhancer of viral particle release.

Authors:  Stephan Bour; Klaus Strebel
Journal:  Microbes Infect       Date:  2003-09       Impact factor: 2.700

Review 6.  Mechanisms of signal-mediated protein sorting in the endocytic and secretory pathways.

Authors:  J S Bonifacino; M S Marks; H Ohno; T Kirchhausen
Journal:  Proc Assoc Am Physicians       Date:  1996-07

7.  Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells.

Authors:  U Schubert; A V Ferrer-Montiel; M Oblatt-Montal; P Henklein; K Strebel; M Montal
Journal:  FEBS Lett       Date:  1996-11-25       Impact factor: 4.124

8.  Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins.

Authors:  Juan Martin-Serrano; Anton Yarovoy; David Perez-Caballero; Paul D Bieniasz; Anton Yaravoy
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-30       Impact factor: 11.205

9.  The protein network of HIV budding.

Authors:  Uta K von Schwedler; Melissa Stuchell; Barbara Müller; Diane M Ward; Hyo-Young Chung; Eiji Morita; Hubert E Wang; Thaylon Davis; Gong-Ping He; Daniel M Cimbora; Anna Scott; Hans-Georg Kräusslich; Jerry Kaplan; Scott G Morham; Wesley I Sundquist
Journal:  Cell       Date:  2003-09-19       Impact factor: 41.582

10.  Independent segregation of human immunodeficiency virus type 1 Gag protein complexes and lipid rafts.

Authors:  Lingmei Ding; Aaron Derdowski; Jaang-Jiun Wang; Paul Spearman
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more
  48 in total

1.  An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein.

Authors:  Stuart J D Neil; Virginie Sandrin; Wesley I Sundquist; Paul D Bieniasz
Journal:  Cell Host Microbe       Date:  2007-09-13       Impact factor: 21.023

2.  Role of the endocytic pathway in the counteraction of BST-2 by human lentiviral pathogens.

Authors:  David Lau; Wilson Kwan; John Guatelli
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

3.  Molecular regulation of lysophosphatidic acid receptor 1 trafficking to the cell surface.

Authors:  Jing Zhao; Jianxin Wei; Rachel K Bowser; Su Dong; Shuqi Xiao; Yutong Zhao
Journal:  Cell Signal       Date:  2014-07-13       Impact factor: 4.315

4.  Conformational changes induced by a single amino acid substitution in the trans-membrane domain of Vpu: implications for HIV-1 susceptibility to channel blocking drugs.

Authors:  Sang Ho Park; Stanley J Opella
Journal:  Protein Sci       Date:  2007-08-31       Impact factor: 6.725

5.  Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.

Authors:  Rachel L Kaletsky; Joseph R Francica; Caroline Agrawal-Gamse; Paul Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-28       Impact factor: 11.205

Review 6.  Tetherin/BST-2: Restriction Factor or Immunomodulator?

Authors:  Sam X Li; Bradley S Barrett; Kejun Guo; Mario L Santiago
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

7.  HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment.

Authors:  Heiko Hauser; Lisa A Lopez; Su Jung Yang; Jill E Oldenburg; Colin M Exline; John C Guatelli; Paula M Cannon
Journal:  Retrovirology       Date:  2010-06-07       Impact factor: 4.602

Review 8.  Human cellular restriction factors that target HIV-1 replication.

Authors:  Klaus Strebel; Jeremy Luban; Kuan-Teh Jeang
Journal:  BMC Med       Date:  2009-09-16       Impact factor: 8.775

9.  Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2.

Authors:  Bin Jia; Ruth Serra-Moreno; William Neidermyer; Andrew Rahmberg; John Mackey; Ismael Ben Fofana; Welkin E Johnson; Susan Westmoreland; David T Evans
Journal:  PLoS Pathog       Date:  2009-05-15       Impact factor: 6.823

10.  Anti-tetherin activities in Vpu-expressing primate lentiviruses.

Authors:  Su Jung Yang; Lisa A Lopez; Heiko Hauser; Colin M Exline; Kevin G Haworth; Paula M Cannon
Journal:  Retrovirology       Date:  2010-02-18       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.